恆科指數跌幅擴至4.5%考驗8,400 京東健康及阿里健康續挫逾8%-9.5%
聯儲局主席鮑威爾指近期國債債息飆升引起他的注意,但並沒提及會否採取應對措施,導致債息進一步飆升,10年期債息升至1.578%,高市值科網股繼續捱沽,Tesla續挫近半成,奈飛續跌1.8%,藍籌蘋果、IBM及英特爾跌1.6%-2.6%,費城半導體指數更續挫4.8%三天累挫逾一成,拖累納指最多急挫3.4%,收12,723,續挫2.1%至逾兩個月低,由上月12日所創紀錄高位更累挫近11%進入調整區。納指一百期貨繼續跑贏,曾再跌逾1%,現造12,338,跌0.9%。
本港恆生科技指數今早低見8,384,創近兩個月低,現造8,424,急挫395點或4.5%。
科指成份股全軍覆沒,跌幅幾乎全面超過2%-5%,其中重磅股騰訊(00700.HK)及美團(03690.HK)最低見667元及321.4元,前者守穩50天線,後者曾失守百天線(321.8元),現造672.5元及326.2元,續跌逾2.5%及4%。
本月中正式「染藍」阿里健康(00241.HK)更急跌近一成,股價失守50天線(25.4元),最低見23.7元,現造23.95元,續挫9.6%。京東健康(06618.HK)四連跌,最低見116元,創近三個月低,現造117.4元,續挫8.3%報。平安好醫生(01833.HK)跌破50天線(101.5元),最低見100.1元,現造100.3元,續跌6.3%。
祖龍娛樂(09990.HK)續跌8.1%報15.38元,創上市新低。明源雲(00909.HK)四連跌,最低見36元,現造37.45元,續跌6.5%。
本月中將被剔除標普道瓊斯指數的小米(01810.HK)最低見23.7元,現造23.9元,續挫6%。華虹(01347.HK)三連跌,最低見42.3元,現造42.85元,續跌6.3%。微盟(02013.HK)四連跌,最低見17.82元,現造19.2元,挫逾6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.